Resmetirom: A Breakthrough Treatment for NASH and Liver Fibrosis

In this video, we discuss a newly FDA-approved medication called Resmetirom, designed for non-cirrhotic non-alcoholic steatohepatitis (NASH) with moderate to advanced liver fibrosis. Watch to learn how Resmetirom works and how it may reverse fibrosis-something not achieved by any existing medication before this groundbreaking research. Taken once daily, it is used alongside diet and exercise to manage NASH.
We’ll also dive into clinical trial results published in the prestigious New England Journal of Medicine (NEJM), covering the drug’s effectiveness, common side effects, and the importance of regular monitoring for safety. Tune in to learn more about this breakthrough in NASH treatment!
Please like and subscribe our channel for more updates like this in the future.
Check out our video on 10 Hottest Medical Innovations: • The 10 Hottest Medical...
Check out our video on New Alzheimer's drug: • Introducing Leqembi - ...